Intratumoral co‐injection of NK cells and NKG2A‐neutralizing monoclonal antibodies

Abstract NK‐cell reactivity against cancer is conceivably suppressed in the tumor microenvironment by the interaction of the inhibitory receptor NKG2A with the non‐classical MHC‐I molecules HLA‐E in humans or Qa‐1b in mice. We found that intratumoral delivery of NK cells attains significant therapeu...

Full description

Bibliographic Details

Published in:	EMBO Molecular Medicine
Main Authors:	Ignacio Melero, Maria C Ochoa, Carmen Molina, Sandra Sanchez‐Gregorio, Saray Garasa, Carlos Luri‐Rey, Sandra Hervas‐Stubbs, Noelia Casares, Edurne Elizalde, Gabriel Gomis, Assunta Cirella, Pedro Berraondo, Alvaro Teijeira, Maite Alvarez
Format:	Article
Language:	English
Published:	Springer Nature 2023-10-01
Subjects:	HLA‐E intratumoral immunotherapy NK NKG2A Qa‐1b
Online Access:	https://doi.org/10.15252/emmm.202317804